Apheresis Market Research Report -Global Forecast To 2027

Apheresis Market Research Report, By Products (Devices and Disposables), By Procedures (Plateletpheresis, Leukapheresis, Erythrocytapheresis, Plasmapheresis), By Methods (Centrifugation And Filtration), By Application (Oncological Diseases, Renal Diseases, Cardiovascular Diseases, Haematological Diseases, Neurological Diseases, Immunological Diseases) And By End Users (Blood Banks, Hospitals) – Global Forecast to 2027

ID: MRFR/MED/0979-HCR | February 2021 | Region: Global | 80 pages

Apheresis Market scenario:


Apheresis is the medical technology which is used for the purification of the blood or separation of different component of blood. It involves removing of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is send back to the donor or patients. This separation of the component was done by two process namely centrifugation and filtration. Global apheresis market is driven by development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases and many more. Increasing demand for the different component of the bloods, rising complex surgical procedures and increasing number of accidents across the globe has also contributed in the growth of the market. According to National Health Service (NHS) Blood and Transplant, the demand for platelets. While lack of skilled professional and Blood and blood product can be infected very easily, this risk of infection also contribute in hindering the market growth.


Apheresis Market is increasing at a rapid pace which is expected to grow at a CAGR of 10.2% during forecasted period 2017-2023.


Apheresis Market Segmentation:


Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures, they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application, the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.


Study Objectives Global Apheresis Market:


Detail analysis of global apheresis market with region specific growth and competitive analysis on the basis of major players present in the market


Detail analysis of global apheresis market and different drivers and restraints affecting the growth of the market


Detailed analysis of the historical and forecasted market analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.


To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global apheresis


Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- Americas, Europe, Asia Pacific and Middle East and Africa.


Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future


Intended Audience



  • Apheresis manufacturers

  • Apheresis suppliers

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Regional analysis:


On regional basis, Americas hold the largest share in the global apheresis market. Continuous advance in technology, increasing opportunity for apheresis products and presence of a huge number of people suffering from different chronic diseases has spurred the growth of this market in Americas. Europe is the second leading market which is followed by Asia Pacific. However Asia Pacific is the fastest growing region for the market. Increasing demand for different blood components for the patients, rapid development in healthcare and increasing healthcare expenditure are contributing in the growth of Asia Pacific apheresis market.


Key Players For Global Apheresis Market:


Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).


Market Assessment


The report for global apheresis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   10.2% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products, Procedures, Methods, Application and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).
  Key Market Opportunities   Increasing demand for the different component of the bloods
  Key Market Drivers   Development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases


Frequently Asked Questions (FAQ) :


Global Apheresis Market can expand at 10.2% CAGR from 2017 to 2023.

Increasing prevalence of blood diseases and advances in apheresis equipment can drive the Global Apheresis Market.

Lack of skilled professionals and probability of infections with equipment are concerns of the Global Apheresis Market.

Americas can dominate the Global Apheresis Market till 2023.

Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo BCT, Inc., Fresenius Medical Care, Haemonetics Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, HemaCare Corporation, and Therakos, Inc. are major players of the Global Apheresis Market.

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL APHERESIS MARKET, BY PRODUCT

5.1 DEVICES

5.1.1 PLASMA SEPARATORS

5.1.2 PLATELETS SEPARATORS

5.1.3 OTHER

5.2 DISPOSABLES

6. GLOBAL APHERESIS MARKET, BY PROCEDURES

6.1 PLATELETPHERESIS

6.2 LEUKAPHERESIS

6.3 ERYTHROCYTAPHERESIS

6.4 PLASMAPHERESIS

6.5 OTHER

7. GLOBAL APHERESIS MARKET, BY METHODS

7.1 CENTRIFUGATION

7.1.1 CONTINUOUS FLOW CENTRIFUGATION

7.1.2 INTERMITTENT FLOW CENTRIFUGATION

7.1.3 OTHER

7.2 FILTRATION

8. GLOBAL APHERESIS MARKET, BY APPLICATION

8.1 ONCOLOGICAL DISEASES

8.2 RENAL DISEASES

8.3 CARDIOVASCULAR DISEASES

8.4 HAEMATOLOGICAL DISEASES

8.5 IMMUNOLOGICAL DISEASES

8.6 NEUROLOGICAL DISEASES

8.7 OTHER

9. GLOBAL APHERESIS MARKET, BY END USERS

9.1 BLOOD BANKS

9.2 HOSPITALS

9.3 OTHER

10. GLOBAL APHERESIS MARKET, BY REGION

10.1 INTRODUCTION

10.2 AMERICA

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 SOUTH AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 ITALY

10.3.1.3 SPAIN

10.3.1.5 UK

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 REPUBLIC OF KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 UNITED ARAB EMIRATES

10.5.2 SAUDI ARABIA

10.5.3 OMAN

10.5.4 KUWAIT

10.5.5 QATAR

10.5.6 REST OF MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

11.1.1 STRATEGIC PARTNERSHIP

11.1.2 MERGER & ACQUISITION

12 COMPANY PROFILE

12.1 HAEMONETICS CORPORATION

12.1.1 OVERVIEW

12.1.2 PRODUCT OVERVIEW

12.1.3 FINANCIALS

12.1.4 KEY DEVELOPMENTS

12.2 FRESENIUS MEDICAL CARE

12.2.1 OVERVIEW

12.2.2 PRODUCT OVERVIEW

12.2.3 FINANCIALS

12.2.4 KEY DEVELOPMENTS

12.3 TERUMO BCT, INC

12.3.1 OVERVIEW

12.3.2 PRODUCT OVERVIEW

12.3.3 FINANCIALS

12.3.4 STRATEGY

12.3.5 KEY DEVELOPMENT

12.4 ASAHI KASEI MEDICAL CO. LTD

12.4.1 OVERVIEW

12.4.2 PRODUCT OVERVIEW

12.4.3 FINANCIALS

12.4.4 KEY DEVELOPMENTS

12.5 HEMACARE CORPORATION

12.5.1 OVERVIEW

12.5.2 PRODUCT OVERVIEW

12.5.3 FINANCIALS

12.5.4 KEY DEVELOPMENTS

12.6 B. BRAUN MELSUNGEN AG

12.6.1 OVERVIEW

12.6.2 PRODUCT OVERVIEW

12.6.3 FINANCIALS

12.6.4 KEY DEVELOPMENTS

12.7 CERUS CORPORATION

12.7.1 OVERVIEW

12.7.2 PRODUCT OVERVIEW

12.7.3 FINANCIALS

12.7.4 KEY DEVELOPMENTS

12.8 OTHER

13 CONCLUSION

14.1 KEY FINDINGS

14.1.1 FROM CEO’S VIEWPOINT

14.1.2 UNMET NEEDS OF THE MARKET

14.2 KEY COMPANIES TO WATCH

14.3 PREDICTION OF APHERESIS INDUSTRY

15 APPENDIX